CAPR - Rasio utang marang kapitalisasi buku capricor.com

Capricor Therapeutics (CAPR) relies on a complex low-temperature biomaterial transport system, which protects raw materials and sustains high profits. This chart of stock quotes confirms the asset's dynamics, with a metric of 0.36. The company is building a scientific ecosystem around exosomes and cellular treatment for cardiovascular pathologies while adhering to strict laboratory waste disposal standards.

CAPR (Capricor Therapeutics, Inc.) riwayat Utang marang nilai buku saka 04.07.2022 nganti 27.10.2026

capricor.com (CAPR) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:

Rega saham Capricor Therapeutics, Inc.|CAPR - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar Capricor Therapeutics, Inc.|CAPR - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Capricor Therapeutics|CAPR - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku capricor.com|CAPR - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Capricor Therapeutics|CAPR - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Capricor Therapeutics, Inc.|CAPR - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Capricor Therapeutics, Inc.

Analisis fundamental perusahaan:Capricor - CAPR

Barang utama Capricor Therapeutics, Inc.

When screening business quality, an investor assesses a company's stability by comparing total liabilities to its equity. This calculated ratio determines the proportion of borrowed funds within the balance sheet structure, which for Capricor Therapeutics (CAPR) confirms management's financial discipline in implementing Duchenne therapy, reflecting this indicator of capital structure risk on the balance sheet.

Pesaing Capricor Therapeutics (CAPR)